Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies

US Patent 9526732 · Granted Dec 27, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of crosslinking glycosaminoglycans2023
Carbohydrate crosslinker2023
Substituted pyrazolo[3,4-d]pyrimidines as mTOR inhibitors2023
Carbohydrate crosslinker2023
Carbohydrate crosslinker2022
MTOR inhibitor compounds2022
Method of crosslinking glycosaminoglycans2022
Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug sub2021
Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan 2020
Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the 2020
Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related or2020
Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-rela2020